BioCentury
ARTICLE | Finance

Histogenics regeneration

Sofinnova leads recap deal for regenerative medicine play Histogenics

August 6, 2012 7:00 AM UTC

Sofinnova Ventures made its first regenerative medicine investment last month when it led a $49 million round that recapped Histogenics Corp.

New investors Split Rock Partners; BioMed Ventures; and FinTech GIMV Fund participated along with existing investors ProChon Holdings; Altima Partners; Foundation Medical Partners; Inflection Point Capital; and Boston Millennia Partners. Boston Equity Advisors was the placement agent...